Calluna Pharma
Oslo
About Calluna Pharma
Calluna has developed a robust pipeline of selective antibodies, targeting immunological diseases. These include novel therapeutic candidates that fulfill unmet clinical needs across a spectrum of diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $81.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2024)
- Website: callunapharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/calluna-pharma-17145 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.